Infrared Light and Mitochondria: The Deep Tissue Connection

Sunlight arrives at your skin carrying an invisible cargo. Beyond the wavelengths your eyes can detect, beyond the ultraviolet that tans and burns, lies a broad band of electromagnetic radiation that passes into your body almost unnoticed: infrared light. It warms you when you step outside on a winter morning. It radiates from the embers of a fire. It constitutes roughly half of all the energy the sun delivers at ground level. And for billions of years, the mitochondria inside every cell of every complex organism on Earth have been quietly absorbing it, responding to it, and using it to generate the chemical fuel that powers life.

The emerging science of photobiomodulation has begun to map this relationship with molecular precision. Researchers now know which protein inside the mitochondrion absorbs infrared photons, how that absorption changes the protein's function, and how that functional change cascades into measurable increases in cellular energy production. What looked like vague claims about "light therapy" a decade ago now has a mechanistic foundation detailed enough to generate testable clinical hypotheses. The picture that emerges is of mitochondria as photoreceptive organelles, embedded in a body shaped by evolution to receive a daily solar light bath that modern indoor life has almost entirely eliminated.

Mapping the Infrared Spectrum

The electromagnetic spectrum organises radiation by wavelength. Visible light occupies a narrow band from roughly 380 to 700 nanometres. Just beyond the red end of the visible spectrum, where the eye's sensitivity fades to nothing, the infrared begins. It extends to approximately 1 millimetre, at which point microwave radiation takes over. This infrared band spans an enormous wavelength range, and physicists and biologists have carved it into three distinct sub-bands that differ profoundly in how they interact with living tissue.

Near-infrared (NIR) occupies 700 to 1400 nm. It is the band closest to visible red light, and it penetrates biological tissue with remarkable efficiency. Mid-infrared (MIR) spans 1400 to 3000 nm. Water begins to absorb strongly in this range, which limits tissue penetration significantly. Far-infrared (FIR) extends from 3000 nm to 1 mm. Water absorbs FIR intensely, meaning these wavelengths are captured almost entirely in the outermost layer of skin. The three bands share a name but behave like three different phenomena, and conflating them in discussions of light therapy has caused considerable confusion in both scientific literature and popular health writing.

From a cellular medicine perspective, near-infrared is the critically important band. It is the wavelength range that reaches mitochondria, penetrates joints and muscles, and crosses the blood-brain barrier to influence neural tissue. It is also the band most abundantly represented in natural outdoor sunlight. The other two bands matter for surface thermal effects and warming, but the deep tissue photochemistry that researchers are most excited about is an NIR story.

Penetration Physics: How Infrared Reaches Deep Tissue

When light encounters biological tissue, three things can happen: it can be reflected at the surface, absorbed by chromophores within the tissue, or scattered by structural elements like collagen fibres and cell membranes. For most visible wavelengths, absorption by haemoglobin and melanin is dominant, which is why the skin appears opaque and why blue or green light barely penetrates a millimetre. Near-infrared occupies a narrow "optical window" in biological tissue where the main absorbers (haemoglobin, melanin, water) all have relatively low absorption coefficients simultaneously.

The practical consequence is striking. Near-infrared light in the 810 to 850 nm range penetrates skin, subcutaneous adipose tissue, and skeletal muscle to depths of 5 to 7 centimetres. Clinical measurements using dosimetry at various tissue depths have confirmed that meaningful photon fluence reaches lumbar spinal structures during surface NIR treatment, that sufficient NIR intensity arrives at knee joint synovium through the skin and suprapatellar fat pad, and that photons penetrate the skull to reach cortical neurons. This is not metaphorical depth. It is literal, measured photon flux at biologically significant intensities, deep inside living bodies.

Far-infrared tells a different story. Water is among the most efficient absorbers of FIR radiation, and living tissue is 70 percent water by weight. FIR photons are therefore captured almost immediately upon entering the skin, depositing their energy as heat in the topmost fraction of a millimetre. FIR saunas and FIR heating panels do produce genuine physiological effects, but those effects are thermal: local vasodilation, increased surface circulation, and relaxation of superficial muscle tension. The mitochondrial photochemistry that makes NIR therapies mechanistically interesting simply does not occur with FIR exposure. Wavelength determines destination.

Cytochrome c Oxidase: The Mitochondrial Photoreceptor

Inside every mitochondrion, the electron transport chain performs the final steps of cellular respiration. Four large protein complexes embedded in the inner mitochondrial membrane pass electrons from NADH and FADH2 through a series of redox reactions to their terminal acceptor, molecular oxygen. This electron flow drives the pumping of protons across the membrane, creating an electrochemical gradient that ATP synthase then uses to phosphorylate ADP into ATP. Complex IV, cytochrome c oxidase (CCO), is the enzyme that receives electrons from cytochrome c and transfers them to oxygen, completing the chain.

Cytochrome c oxidase contains four metal centres that participate in electron transfer: two copper centres (CuA and CuB) and two iron-porphyrin haem groups (haem a and haem a3). These metal chromophores absorb light across a broad spectrum, but their absorption peaks cluster specifically in the red and near-infrared range, between approximately 600 and 900 nm. This is not a coincidence of biochemistry. It reflects an evolutionary alignment between the absorption properties of the enzyme's chromophores and the wavelengths most abundantly available in natural outdoor light. Cytochrome c oxidase is, in the most literal sense, a mitochondrial photoreceptor tuned to sunlight.

The identity of cytochrome c oxidase as the primary chromophore for red and NIR light in living tissue was established by Tiina Karu at the Russian Academy of Sciences in the 1980s and 1990s. Using action spectra measurements that mapped biological response against wavelength, Karu demonstrated that the wavelengths most effective at stimulating cellular responses matched the absorption spectrum of oxidised cytochrome c oxidase. This finding positioned CCO as the mechanistic linchpin of photobiomodulation and provided the field with its first rigorous molecular hypothesis for how light at these wavelengths could produce biological effects.

The Nitric Oxide Dissociation Mechanism

Understanding why cytochrome c oxidase absorbs NIR light is only half the puzzle. The other half is what happens as a result. For a long time, researchers could demonstrate that NIR exposure increased ATP production, reduced oxidative stress markers, and accelerated wound healing, but the causal chain between photon absorption and those downstream effects was unclear. The mechanistic breakthrough came from understanding the role of nitric oxide as a physiological regulator of cytochrome c oxidase activity.

Nitric oxide (NO) is a gaseous signalling molecule synthesised throughout the body, including in mitochondria themselves. At physiological concentrations, NO binds to the binuclear centre of cytochrome c oxidase (the CuB and haem a3 site where oxygen reduction occurs) and competitively inhibits oxygen binding. This partial inhibition is not pathological; it is a normal regulatory mechanism that modulates mitochondrial respiration rate in response to local metabolic demands and oxygen availability. But when NO binding becomes excessive (under conditions of inflammation, hypoxia, or elevated cellular stress) it acts as a brake on ATP synthesis, contributing to the energy deficits associated with many chronic conditions.

When NIR photons are absorbed by the metal chromophores of cytochrome c oxidase, they supply energy sufficient to photodissociate the NO-enzyme bond. The inhibitory nitric oxide is released into solution, the active site reopens for oxygen binding, and electron transport resumes at full rate. The proton gradient increases, ATP synthase spins faster, and cellular ATP output rises. The released NO diffuses to neighbouring cells, where it acts as a vasodilator and signalling molecule, generating secondary effects including increased local blood flow, reduced inflammation, and altered gene expression through NO-sensitive transcription factors. A single photon-enzyme interaction ramifies outward through the entire cellular energetic and signalling architecture.

The Science of Aging Retinas: Glenn Jeffery and the 670nm Discovery

Among the most compelling experimental evidence for mitochondrial photobiomodulation comes from a research programme at University College London led by neuroscientist Glenn Jeffery. Jeffery's laboratory focuses on aging of the retina, a tissue that is among the most metabolically demanding in the body. Retinal photoreceptors consume enormous quantities of ATP to maintain ion gradients and drive the phototransduction cascade, and their mitochondrial density is correspondingly high. With age, mitochondrial function in photoreceptors declines, contributing to the progressive loss of visual sensitivity that is one of the most ubiquitous aspects of human aging.

Jeffery's group demonstrated in animal models that brief daily exposures to 670 nm light (in the red and near-infrared boundary range) significantly improved retinal mitochondrial function in aged animals, slowing age-related photoreceptor decline. The mechanism aligned precisely with the nitric oxide photodissociation hypothesis: the 670 nm photons activated cytochrome c oxidase in retinal mitochondria, boosted ATP production in the energy-starved photoreceptors, and reduced the oxidative damage associated with mitochondrial dysfunction. The effect was dose-dependent and wavelength-specific, with control wavelengths outside the CCO absorption spectrum producing no comparable benefit.

These preclinical findings led to a landmark human clinical study published in the journal Journals of Gerontology in 2021, and subsequently to a 2023 Nature Aging paper that attracted widespread attention. In the 2023 study, participants over 40 years of age received brief daily exposures (three minutes per day) to 670 nm LED panels for two weeks. Colour discrimination ability, contrast sensitivity, and overall visual function improved significantly compared to controls, with the effects persisting for weeks after the intervention ended. The magnitude of improvement in participants over 70 was particularly striking, suggesting that the mitochondrial reserves in aged photoreceptors remained responsive to photonic stimulation even after decades of decline. This was not restoring youth; it was demonstrating that mitochondrial photoreception remains functional and therapeutically accessible even in significantly aged tissue.

Sunlight: The Original Mitochondrial Signal

The existence of a mitochondrial protein exquisitely tuned to absorb NIR wavelengths from natural sunlight is not a curiosity of biochemistry. It is an evolutionary signature. Cytochrome c oxidase is ancient, conserved across billions of years of evolution from prokaryotes to complex mammals. The protein's chromophore architecture was shaped by selection pressure operating in environments where NIR radiation from sunlight was a constant daily signal. The alignment between the solar NIR spectrum and CCO's absorption peaks is not coincidental; it reflects a deep evolutionary coupling between mitochondrial function and the photonic environment of outdoor life.

Natural sunlight at ground level delivers approximately 50 percent of its energy as infrared radiation, with NIR constituting the majority of that fraction. A person spending several hours outdoors in moderate sunlight receives a substantial daily dose of NIR photons across their entire body surface. These photons penetrate the skin, reach the dense mitochondrial populations in dermal fibroblasts and underlying muscle, and continuously modulate cytochrome c oxidase activity throughout the exposure. This is the context in which human mitochondria evolved to function.

Modern indoor life has severed this signal almost entirely. Standard window glass transmits visible light efficiently but blocks a significant fraction of the NIR spectrum. LED and fluorescent indoor lighting is spectrally deficient in NIR by design (thermal emission of NIR is energy waste in an artificial lighting context). Office workers, students, and most urban adults spend 90 percent or more of their waking hours under spectral conditions that would have been encountered by ancestral humans only inside a cave. The mitochondrial implication is that a photonic input that shaped enzyme function for billions of years has been removed from the daily environment in the span of a few generations.

This framing contextualises red light therapy not as an exotic intervention but as a technological attempt to restore a photonic input that the human body was built to receive. The question is not whether adding NIR to the cellular environment changes mitochondrial function. The evidence clearly shows it does. The question is whether the absence of NIR from modern environments is contributing to the spectrum of metabolic and mitochondrial disorders that characterise contemporary human health.

Therapeutic Applications and the Clinical Frontier

The mechanistic framework around cytochrome c oxidase and NIR photodissociation has opened clinical research in several directions. The broadest body of evidence addresses musculoskeletal applications. Skeletal muscle is one of the most mitochondria-dense tissues in the body, and its recovery from exercise-induced damage is intimately tied to mitochondrial function. Multiple randomised controlled trials have demonstrated that pre- or post-exercise NIR exposure reduces delayed onset muscle soreness, accelerates recovery of force production, and decreases blood markers of muscle damage including creatine kinase. The effects are consistent with improved mitochondrial ATP availability during the repair and remodelling phase following exertion.

Joint pathology represents another active area. Synovial tissue and cartilage are poorly vascularised and dependent on diffusion for their oxygen and nutrient supply, making them particularly vulnerable to mitochondrial inefficiency. NIR can reach knee and shoulder joints at clinically relevant fluence through surrounding soft tissue, and clinical studies in osteoarthritis patients show improvements in pain scores and functional measures that exceed placebo at NIR wavelengths within the CCO absorption range. Rheumatoid arthritis research is earlier in its development, but the anti-inflammatory effects of NO signalling following CCO photodissociation provide a plausible mechanism for immune-mediated joint disease.

Neuroprotection is perhaps the most scientifically exciting frontier. Neurons are extraordinarily ATP-demanding, and neurological diseases from Parkinson's disease to traumatic brain injury to Alzheimer's disease all feature mitochondrial dysfunction as an early and central feature. Transcranial NIR delivery has been shown to penetrate the skull and reach cortical tissue in human cadaveric and live human studies using NIR spectroscopy verification. Early clinical trials in traumatic brain injury, stroke, and Parkinson's disease have reported neurological improvements with transcranial NIR protocols, with several larger placebo-controlled trials underway. Wound healing, which relies on fibroblast proliferation and collagen synthesis driven by ATP availability, was among the earliest validated applications and remains well-supported in the literature.

Mitochondrial Photobiomodulation as a New Paradigm

The convergence of mechanistic biochemistry, action spectroscopy, clinical trial data, and evolutionary biology around the cytochrome c oxidase photoreceptor hypothesis represents something more significant than a new treatment modality. It represents a conceptual shift in how we understand the relationship between light environments and cellular function. For most of the 20th century, light was understood to interact with biology primarily through three channels: vision (photoreception by rod and cone opsins), circadian entrainment (melanopsin in ipRGCs), and UV-induced DNA damage or vitamin D synthesis. The mitochondrial photoreceptor system adds a fourth channel, one that operates continuously in all nucleated cells, responds to a different portion of the spectrum, and modulates the most fundamental of all cellular functions: energy production.

This paradigm has implications that extend well beyond the clinic. It suggests that the spectral composition of environments (not just their light intensity or photoperiod) is a biologically significant variable that medicine has not previously measured or controlled. It raises the question of whether spectral deficiency of the indoor light environment contributes to the prevalence of mitochondrial disorders, chronic fatigue, poor tissue recovery, and accelerated biological aging that characterise modern sedentary indoor populations. And it suggests that some of the health benefits attributed to outdoor exercise and sun exposure may be mediated not only by physical exertion and vitamin D, but by the continuous NIR photonic input that outdoor environments deliver to every mitochondrion in every cell of the body.

The science of mitochondrial photobiomodulation is still young. Many clinical applications remain in early trial phases, dose optimisation protocols are still being refined, and the full range of downstream signalling effects continues to be mapped. But the core mechanism is no longer speculative. Cytochrome c oxidase absorbs near-infrared photons. Those photons dissociate inhibitory nitric oxide. Electron transport accelerates. ATP production increases. Downstream signalling cascades propagate through the cell. This is testable, reproducible, and mechanistically coherent in a way that places it firmly within mainstream photobiology and bioenergetics.

The ancient photonic relationship between sunlight and the mitochondrion, shaped by billions of years of evolution, is not a mystic concept. It is a molecular interaction between a protein and a photon, now understood in enough detail to reproduce therapeutically and to track with enough precision to optimise clinically. What we are learning, with increasing confidence, is that human mitochondria were built to receive light. And that removing them from the light, as modern life has done, may have consequences that medicine is only beginning to measure.